Puma Biotechnology Inc

Puma Biotechnology Inc

PBYI - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$538.91M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Puma Biotechnology IncPuma Biotechnology Inc19.5-19%2.7-
$16.61

Current Fair Value

55.4% upside

Undervalued by 55.4% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$538.91 Million
Enterprise Value$507.23 Million
Earnings per Share$0.62
Beta1.21
Outstanding Shares50,939,946

Return

Return on Equity19.22%ROE
Return on Assets13.82%
Return on Invested Capital22.67%

Valuation & Multiples

P/E Ratio19.47P/E Ratio
PEG48.84PEG
Price to Sales2.67Price to Sales
Price to Book Ratio5.35Price to Book Ratio
Enterprise Value to Revenue2.19
Enterprise Value to EBIT15.66
Enterprise Value to Net Income19
Total Debt to Enterprise0.01
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 29, 2026
EPS Estimate
$0.09
Consensus analyst estimate
Revenue Estimate
$57.50 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 29.50%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %1.59%▼ 74.60%
Total Invested$8.04M▼ 97.45%
Investors Holding36▼ 130.00%

About Puma Biotechnology Inc

Puma Biotechnology Insider Information FAQ

Stockcircle tracks 2 top investors with a current 13F position in Puma Biotechnology. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 10 open-market insider sales for Puma Biotechnology in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.